Rousu MC, Monchuk DC, Shogren JF, Kosa KM. Consumer willingness to pay for “second generation” genetically engineered products and the role of market information. J Agr Appl Econ. 2005 Dec;37(3):647-57. doi: 10.1017/S1074070800027140
Mangel AW, Fehnel SE. Global endpoints in functional gastrointestinal disease. Aliment Pharmacol Ther. 2005 Dec 1;22(11-12):1162-3.
Ryan M, Diack J, Watson V, Smith N. Rapid prenatal diagnostic testing for down syndrome only or longer wait for full karyotype: the views of pregnant women. Prenat Diagn. 2005 Dec;25(13):1206-11. doi: 10.1002/pd.1309
Havrilesky LJ, Cragun JM, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol. 2005 Dec 1;99(3):689-95.
Hutchison R, Mordin MM, Albright Y, Zhang M, Vallow S. Hospital resources associated with intravenous patient-controlled analgesia in the management of acute pain following orthopedic or gynecologic surgery. Poster presented at the Midyear Clinical Meeting of the American Society of Health-System Pharmacists; December 2005.
Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen VZ, Hamm LR, Mangel AW, Tennis P, Cook SF. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005 Nov 10;22:935-42.
Wolowacz SE, Roskell NS, Christie A, Kerr G, Cameron D. The cost of hospital care for relapsed breast cancer in the UK based on a large patient-level resource utilisation dataset. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy.
Earnshaw SR, Javitt JC, Zlateva GP, Pleil AM, Graham CN, Brogan AJ, Shah S, Adamis AP. Cost-effectiveness model for age-related macular degeneration: comparing Macugen® to Visudyne®. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy.
Gregson N, Sparrowhawk K, Mladsi DM. Global pricing and reimbursement strategy: an integrated analytical framework. Presented at the 2005 ISPOR 8th Annual European Congress; November 8, 2005. Florence, Italy.
Johnson FR, Mladsi DM, Sparrowhawk K. Conjoint analysis: application to global pricing and reimbursement strategy. Presented at the 2005 ISPOR 8th Annual European Congress; November 7, 2005. Florence, Italy.
Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.
Whalley D, Bojke C, Gravelle H, Sibbald B. The role of general practitioners' evaluative assessments of job design and time pressures in job satisfaction. Poster presented at the Northwest Regional Scientific Meeting of the Society for Academic Primary Care; November 2005.
Doward LC, McKenna SP, Meads DM, Kavyasiddhi D, Hampson NE, Mayo KW. The symptomatic, functional and quality of life impact of multiple sclerosis: report on a qualitative investigation of the patients' perspective. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A135.
Hampson NE, Meads DM, McKenna SP, Doward LC, Turk F. Factors influencing quality of life in atopic dermatitis. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A149.
Zhou X, Radigue C, Maneval F, Coste F. Validity of data collected from an internet-based cohort study. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 8, 2005. Florence. [abstract] Value Health. 2005 Nov; 8(6):A76.
Wolowacz SE, Roskell NS, Christie A, Kerr G, Cameron D. Per-patient cost of hospital care for advanced breast cancer in the UK based on a large patient-level resource utilisation dataset. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A42.
Sorensen HT, Pedersen L, Norgaard M, Wogelius P, Rothman KJ. Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology. 2005 Nov 1;16(6):806-7.
Earnshaw SR, Javitt JC, Graham CN, Brogan AJ, Zlateva GP, Shah S, Adamis AP. Modeling treatments for subfoveal choroidal neovascularization secondary to age-related macular degeneration: cost-effectiveness methods. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A179.
Earnshaw SR, Javitt JC, Zlateva GP, Pleil AM, Graham CN, Brogan AJ, Shah S, Adamis AP. Cost-effectiveness model for age-related macular degeneration: comparing early and late Macugen® treatment. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6).
Guh S, Poulos C. Comparison of cost-of-illness to willingness-to-pay to avoid an episode of shigellosis in a rural area of China. Poster presented at the 27th Annual APPAM Research Conference: Understanding and Informing Policy Design; November 2005.
Hill CD, Fehnel SE, Hogue SL. Patient-perceived differences among commonly used antidepressants: a web-based survey. Poster presented at the US Psychiatric & Mental Health Congress; November 1, 2005.
Hahn EJ, Rayens MK, Warnick TA, Chirila C, Rasnake RT, Paul TP, Christie D. A controlled trial of a quit and win contest. Am J Health Promot. 2005 Nov 1;20(2):117-26.
Abetz L, Coombs JH, Keininger DL, Earle CC, Wade C, Bury-Maynard D, Copley-Merriman K, Hsu MA. Development of the cancer chemotherapy satisfaction questionnaire (CCSQ): item generation and content validity testing. Value Health. 2005 Nov;8(Suppl 1):S41-53.
Sunyer J, Zock JP, Kromhout H, Garcia-Esteban R, Radon K, Jarvis D, Toren K, Kunzli N, Norback D, d'Errico A, Urrutia I, Payo F, Olivieri M, Villani S, Van Sprundel M, Anto JM, Kogevinas M, Occupational Group of the European Community Respiratory Health Survey. Lung function decline, chronic bronchitis, and occupational exposures in young adults. Am J Respir Crit Care Med. 2005 Nov 1;172(9):1139-45. doi: 10.1164/rccm.200504-648OC.
Fehnel S, McLeod LD, Edin HM, Hogue SL. Psychometric evaluation of the motivation and energy inventory – short form (MEI-SF). Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 22, 2005. San Francisco, CA.
Williams V, Morlock R, Fehnel S, Wills MM, Hill CD, Barrows S, Cappelleri J, Feltner D. Development and evaluation of the daily assessment of symptoms–anxiety (DAS-A) scale for measurement of onset of symptom relief in patients with gad. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.
Britt DM, Fehnel SE, Granger AL, Zhou X, Williams R. Quality of life and the prevalence of vasomotor symptoms in a population-based sample of peri- and post-menopausal women. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.
McLeod LD, Fehnel SE, Willis MM, Hamm LR, Gilchrist KA. Psychometric validation of a patient-reported instrument assessing functional status in bipolar disorder. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.
Pignone M, Earnshaw SR. Cost-effectiveness of aspirin for the primary prevention of cardiovascular events in women. Poster presented at the Society of Medical Decision Making; October 2005.
Fehnel SE, Edin HM, McLeod LD, Hogue SL. Development and preliminary psychometric evaluation of the motivation and energy inventory – short form (MEI-SF). Poster presented at the 18th Congress of the European College of Neuropsychopharmacology; October 2005. Previously presented at the ISOQOL 2004 Symposium.
Nijsten T, Whalley D, Gelfand J, Margolis D, McKenna SP, Stern RS. The psychometric properties of the psoriasis disability index in United States patients. J Invest Dermatol. 2005 Oct 1;125(4):665-72.
Earnshaw SR, Candrilli SD, Fernandes AW, Higashi MK. A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumonia. Managed Care Interface. 2005 Oct 1;18(10):36-44.
Kim D, Dong B, Poulos C, Whittington D, Serre M, Nyamete A. Gis-based spatial approach to estimating private demand for vaccination programs: evidence from Lingchuan County, China. Poster presented at the Association of Collegiate Schools of Planning: Beyond the City Beautiful; October 2005.
Hoyo C, Berchuck A, Halabi S, Bentley RC, Moorman P, Calingaert B, Schildkraut JM. Anthropometric measurements and epithelial ovarian cancer risk in african–american and white women. Cancer Causes Control. 2005 Oct 1;16(8):955-63.
DeMuro-Mercon CJ, Mast TC, Floyd LE, Walters C. Assessing the impact of rotavirus gastroenteritis on the family. Presented at the National Conference and Exhibitions of the American Academy of Pediatrics; October 2005.
Ellison RC, Rothman KJ, Zhang Y, Djousse L. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med. 2005 Oct 1;29(3):243.
Delea T, Hagiwara M, Borker R, Stanford R. Observational study of the risk of ED visit or hospitalization in COPD patients receiving maintenance therapies: a time-dependent analysis. Presented at the 71st Annual Chest International Meeting; October 2005. Montreal, Canada. [abstract] Chest. 2005 Oct; 128(4 Supplement):178S. doi: 10.1378/chest.128.4_MeetingAbstracts.178S-a
Nathan RA, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauffer JL, Philpot E, Dorinsky PM, Nelson HS. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest. 2005 Oct;128(4):1910-20. doi: 10.1378/chest.128.4.1910
Borker RD, Watkins M, Knobil K, Emmett A, Kalberg C. Using distribution-based standard error of measurement (SEM) method to determine minimal important difference (MID) for the symptom status index (SSI). Poster presented at the CHEST 2005: 71st Annual Meeting of the American College of Chest Physicians; October 29, 2005. Montreal, Canada. [abstract] Chest. 2005 Oct; 128(4 supplement):251S.
Borker RD, Hayflinger C, Stanford R. Risk of hospitalization/emergency visit in patients with chronic obstructive pulmonary disease by initial medication regimen. Poster presented at the CHEST 2005: 71st Annual Meeting of the American College of Chest Physician; October 2005. [abstract] Chest. 2005 Oct; 128(4 Supplement):257S.
Riedel A, Chastek B, Borker RD. Healthcare and economic burden in undiagnosed chronic obstructive pulmonary disease (COPD) patients. Presented at the 71st Annual Chest International Meeting; October 2005. Montreal, Canada. [abstract] Chest. 2005 Oct; 128(4 Supplement):123S.
Colman SS, Nixon A, Barrows SM, Taylor TN, Miller T. Qualitative research methods: development of a hyperpigmentation treatment satisfaction with medication questionnaire. Poster presented at the Annual Meeting of the International Society for Quality of Life Research; October 2005.
Portenoy R, Cleeland C, Backonja M, Moskowitz R, Parsons B, McLeod LD. A new validated patient-completed neuropathic pain screening tool for use in the primary care setting. Poster presented at the 66th American Academy of Physical Medicine and Rehabilitation Annual Assembly; October 2005.
Hamilton J, Mordin MM, Zhang M, Olson W, Hewitt D. Logistics of intravenous patient-controlled analgesia in the treatment of acute pain following orthopedic or gynecologic surgery. Poster presented at the Annual Meeting of the American Society of Anesthesiologists; October 2005.
Ettinger B, Earnshaw SR, Graham CN, Amonkar MM, Baran RW. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with ibandronate. Poster presented at the American Society for Bone and Mineral Research (ASBMR) 27th Annual Meeting; September 2005.
Rothman KJ, Arellano F. Elevating the level of scientific discourse. Int J Occup Environ Health. 2005 Sep 1;11(3):327-8.
Johannes CB, Chiang CC, Ng EW, Eng PM, Seeger JD, Walker AM. Treatment patterns in patients using biological disease modifying antirheumatic therapy for rheumatoid arthritis. Presented at the 21st International Conference on Pharmacoepidemiology; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Sep; 14(Suppl 2):S195. doi: 10.1002/pds.1136
Mordin MM. Practical applications of pharmacoeconomic and outcomes research in phase iv studies. Poster presented at the CBI's 6th Annual Phase IV Clinical Trials Conference: Design Research Programs to Meet Clinical, Regulatory and Marketing Objectives; September 2005. Philadelphia, PA.
DiBenedetti DB, Gondek K, Sagnier PP, Kubin M, Keininger D, Marquis P. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol. 2005 Sep 1;48(3):503-11.